Wednesday, Oct 15, 2025 · SEC filings
What the smart money revealed on Oct 15
297 insider filings came in. We hid 65 planned (10b5-1) sellers and 182 people whose filings were routine, like grants and tax withholding.
3 insiders at Volitionrx (VNRX) bought $130K of stock
Roles: CEO, Director. Several insiders buying in the same few days is rare.
Commercial Bancgroup (CBK) Director James Shoffner bought $350K
14,583 shares on the open market. Not a grant or an option exercise.
Commercial Bancgroup (CBK) Director Charles Yates bought $200K
8,333 shares on the open market. Not a grant or an option exercise.
Quoin Pharmaceuticals (QNRX) Director Dennis Langer bought $129K
15,152 shares on the open market. Not a grant or an option exercise.
Resources Connection (RGP) President & CEO Kate Duchene bought $100K
23,015 shares on the open market. Not a grant or an option exercise.
Grindr (GRND) Director James Lu sold $8.12M
Not marked as a planned 10b5-1 sale. Sold 3% of the shares they held directly. Still holds 24.94M shares.
Argan (AGX) CEO Charles Collins sold $2.92M
Not marked as a planned 10b5-1 sale. Sold 32% of the shares they held directly. Still holds 21,006 shares.
Ferguson Enterprises (FERG) Officer James Paisley sold $711K
Not marked as a planned 10b5-1 sale. Sold 58% of the shares they held directly. Still holds 2,211 shares.
Show 2 more real buys
Show 21 more real sales
13F season
Holdings as of Sep 30, 2025 are due Nov 14
81 funds have filed so far. 74 filed for the quarter before.
Biggest real insider buys, Oct 9–15
Open-market buys by officers and directors, filed in the 7 days up to Oct 15.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.